Form D · Biotechnology
RegenX Science Inc.
West Palm Beach, FL · CIK 0001797220
Offering snapshot reported Sep 20, 2022 · SEC filing
- Reported sold
- $5M Offering amount: $7M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Sep 15, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2022 | Initial | $5,000,000 | No comparison | 43 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-459323
Source: Form D, filed Sep 20, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zheng Cao | Executive |
| Elisabeth Corson | Director, Executive |
| Zach Ferrell | Director |
| Jill Waibel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
319 Clematis Street Suite 408
West Palm Beach, FL, 33401
West Palm Beach, FL, 33401